Apyx Medical Corporation
Apyx Medical Corporation Initiates Enrollment in Study Evaluating the Use of Renuvion® Technology in Skin Laxity Procedures in the Neck and Submental Region
The study is a prospective, multi-center, multi-phase, evaluator-blinded study designed to evaluate the safety and effectiveness of Renuvion technology when used to improve the appearance of lax tissue in the neck and submental region.
Apyx Medical Corporation
Launch of Renuvion™: A New Brand Dedicated to the Cosmetic Surgery Market Announced by Bovie Medical Corporation
3/29/18: Bovie Medical’s J-Plasma technology will now be marketed and sold in the cosmetic surgery market under the brand name, Renuvion.
Apyx Medical Corporation
Bovie Medical Receives 510K Clearance for its J-Plasma® Precise Flex Handpiece
The Addition of the J-Plasma® Precise Flex rounds out Bovie Medical’s J-Plasma® offering to include products designed...
Apyx Medical Corporation
Boston Scientific to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017...
Apyx Medical Corporation
Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece
Bovie Medical (NYSE:BVX) announced today that it has received 510K clearance from the FDA for a new...
